Loading organizations...

§ Private Profile · Los Angeles, CA, USA
Salt AI is a technology company.
Salt AI provides a programmable system offering contextual artificial intelligence solutions tailored for the life sciences and healthcare sectors. The company's platform integrates specialized models and datasets to create interpretable and auditable AI workflows. It is engineered to facilitate the deployment, development, optimization, and operation of multi-model systems within highly regulated, scientific, and operational environments, emphasizing compliance and reliability.
The company was co-founded in 2023 by Aber Whitcomb, who leads as CEO, and Jim Benedetto, the Chief Technology Officer. Their combined experience led to the realization that regulated industries required a more structured and transparent approach to AI adoption. The founding insight centered on enabling organizations to harness AI effectively by connecting disparate models and data sources into cohesive, smarter operations.
Salt AI targets life sciences and healthcare organizations, empowering their teams to address intricate biological challenges with advanced AI. The company envisions a future where these sectors can confidently deploy secure and compliant AI, ensuring that every implementation is both impactful and dependable. Their long-term goal is to make sophisticated AI accessible and trustworthy across vital research and operational domains.
Salt AI has raised $23.0M across 3 funding rounds.
Salt AI has raised $23.0M in total across 3 funding rounds.
Salt AI is a Los Angeles–based startup building a *contextual, visual-first platform* that lets life‑sciences and healthcare teams compose, run, and govern multi‑model AI workflows for research, drug development, and clinical evidence tasks[5][4]. Salt positions itself as a model‑agnostic “collaborative operating system” that makes AI accessible to non‑engineers while meeting enterprise needs for compliance, scalability, and data sovereignty[5][4].
High‑level overview
For product/context (company view)
Origin story
Core differentiators
Role in the broader tech landscape
Quick take & future outlook
Quick take: Salt AI combines domain focus (life sciences), a visual, model‑agnostic orchestration layer, and enterprise deployment options to address a clear pain point—making regulated, multi‑model AI workflows usable by non‑engineers—positioning it well to accelerate AI adoption in biotech and clinical research[5][3][4].
Salt AI has raised $23.0M in total across 3 funding rounds.
Salt AI's investors include Morpheus Ventures, Brian Venturo, Marbruck Investments, Struck Capital, Blackbird Ventures Australia, Index Ventures, Insight Partners, Bill Tai, CoreWeave, Irregular Expressions.
Salt AI has raised $23.0M across 3 funding rounds. Most recently, it raised $10.0M Other Equity in September 2025.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Sep 22, 2025 | $10M Venture Round | Morpheus Ventures | Brian Venturo, Marbruck Investments, Struck Capital | Announced |
| Sep 1, 2025 | $10M Seed | Morpheus Ventures | Blackbird Ventures Australia, Index Ventures, Insight Partners, Bill TAI, CoreWeave, Marbruck Investments, Struck Capital | Announced |
| Dec 1, 2024 | $3M Seed | Morpheus Ventures | Blackbird Ventures Australia, Index Ventures, Insight Partners, Bill TAI, Irregular Expressions, Struck Capital | Announced |